Last update :
27/11/2024
Research teams - University of California Davis medical center, Department of Pharmacy Services   pdf  
United States of America
Hospital
University of California Davis medical center, Department of Pharmacy Services
Sacramento
Email
References   References   (6)  
1
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC. ()
Ann Pharmacotherapy - 2004 - ; 38: 569-573.
2
Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies.
Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH. ()
Clinical Cancer Research - 2001 - ; 7: 1569-1576.
3
Visual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injection.
Mantong ML, Marquardt ED. ()
Am J Health-Syst Pharm - 1995 - ; 52: 2567-2568.
4
Visual compatibility of fluconazole with drugs given by continuous infusion.
Ishisaka DY. ()
Am J Hosp Pharm - 1994 - ; 51: 2290,2292.
5
Visual compatibility of indomethacin sodium trihydrate with drugs given to neonates by continuous infusion.
Ishisaka DY, van Vleet J, Marquardt E. ()
Am J Hosp Pharm - 1991 - ; 48: 2442-2443.
6
Visual compatibility of hydroxyzine hydrochloride with various antineoplasic agents.
Marquardt ED. ()
Am J Hosp Pharm - 1988 - ; 45: 2127.

List of drugs   Molecules studied   (40)  

  Mentions Légales